Ketamine-induced changes in accumbal glutamate and their association with altered states of consciousness.
Ladina Philomena Gubser, Anna Stefania Trippel, Niklaus Zoelch, Etna Jennifer Elektra Engeli, Marcus Herdener
Brain Research Bulletin May 1, 2026 DOI: 10.1016/j.brainresbull.2026.111842 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Within-subjects experimental study Peer reviewed |
|---|---|
| Sample size | 10 |
| Population | Healthy volunteers |
| Interventions | R S-ketamine |
| Dose | 0.71 mg/kg bodyweight |
| Duration | 40-minute infusion |
| Topics | Ketamine Altered states of consciousness Esketamine |
| Keywords | Altered Consciousness Glutamate Nucleus accumbens Spectroscopy |
| Key findings | Ketamine did not significantly increase mean glutamate levels in the NAc, but individual glutamate changes were positively associated with anxious ego dissolution and reductions in vigilance. |
Abstract
Ketamine has been shown to modulate glutamate signaling in animals and may therefore have the potential to restore glutamate imbalances in the brain. Impaired glutamate homeostasis has been implicated in mental health disorders such as substance use disorders (SUDs). Thus, we investigated ketamine's potential to increase glutamate levels in the nucleus accumbens (NAc), a key region for the development and maintenance of SUD. We further examined whether glutamate changes are associated with ketamine's potential to induce altered states of consciousness. A single intravenous dose of R,S-ketamine (0.71 mg/kg bodyweight) was administered to 10 healthy volunteers over 40 min. Glutamate levels were measured by using a tailored proton magnetic resonance spectroscopy (1H-MRS) sequence in the left NAc on a 3 T scanner, before and during the infusion. Subjective effects were measured by using the Five-Dimensional Altered States of Consciousness (5D-ASC) questionnaire. Glutamate levels were considered from the overall spectrum average (22 min) as well as three shorter, overlapping sub-blocks (each 10 min), to capture the progression of glutamate over time. Mean glutamate levels in the NAc were not significantly altered between baseline and ketamine 1H-MRS measurement. However, glutamate changes were positively associated with anxious ego dissolution and reductions in vigilance. In conclusion, ketamine did not significantly increase glutamate levels across our sample of 10 healthy volunteers, but individual glutamate changes induced by ketamine correlate with anxious ego dissolution and reductions in vigilance, indicating that ketamine-induced glutamate alterations in the NAc underly specific alterations in perception and consciousness.
Comparable studies
Other experimental studies on altered states of consciousness, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| The Standardized Psychometric Assessment of Altered States of Consciousness (ASCs) in Humans Healthy subjects in six countries | 1998 | Experimental and field study | n = 1,133 |
| TMS-EEG and resting-state EEG applied to altered states of consciousness: oscillations, complexity, and phenomenology. | 2023 | Experimental study | |
| A Test of the Psychedelic Model of Altered States of Consciousness | 1976 | Experimental study with comparison groups | |
| Neural Correlates of Non-ordinary States of Consciousness in Pranayama Practitioners: The Role of Slow Nasal Breathing Experienced meditators | 2022 | Within-subjects comparison | n = 12 |
| Increased spontaneous EEG signal diversity during stroboscopically-induced altered states of consciousness Healthy adults | 2019 | Experimental study |
Citations in the library
Cites 37
- Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans Archives of General Psychiatry March 1, 1994
- Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex Journal of Neuroscience April 15, 1997
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms Pharmacological Reviews June 26, 2018
- Measurement of dissociative states with the Clinician‐Administered Dissociative States Scale (CADSS) Journal of Traumatic Stress 1998
and 32 more in the library